TOFACITINIB CITRATE
NDC 68254-5012, TOFACITINIB CITRATE, tablet, film coated, from CONCORD BIOTECH LIMITED.
- Product NDC
- 68254-5012
- Status
- Listed
- Labeler
- CONCORD BIOTECH LIMITED
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218821
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68254-5012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFACITINIB CITRATE16.16 mg/1
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68254-5012-1 | 68254501201 | 28 TABLET, FILM COATED in 1 BOTTLE (68254-5012-1) |
| 68254-5012-2 | 68254501202 | 60 TABLET, FILM COATED in 1 BOTTLE (68254-5012-2) |
| 68254-5012-3 | 68254501203 | 180 TABLET, FILM COATED in 1 BOTTLE (68254-5012-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/6c33e5b4-4843-4a80-a4f8-435bfceddc2a
Use it
Look up 68254-5012 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68254-5012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68254-5012. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.